Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05844059

Lower Urinary Tract Symptoms After Intravesical Therapy

Lower Urinary Tract Symptoms After Intravesical Therapy With Mitomycin C or BCG in Patients With Carcinoma of the Bladder

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Ludwig-Maximilians - University of Munich · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.

Conditions

Interventions

TypeNameDescription
OTHERValidated questionnairesBPIC-SS, ICIQ-OABqol, IIEF-EF oder FSFI, ICIQ-MLUTS oder ICIQ-FLUTS

Timeline

Start date
2023-04-21
Primary completion
2025-04-24
Completion
2026-04-24
First posted
2023-05-06
Last updated
2023-05-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05844059. Inclusion in this directory is not an endorsement.

Lower Urinary Tract Symptoms After Intravesical Therapy (NCT05844059) · Clinical Trials Directory